Bayer, DE000BAY0017

Bayer stock at EUR 44.66 ahead of the Xetra open: health group rises 1.55 percent

Published on 10/26/2026 at 08:20 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
The group covers Crop Science, Pharmaceuticals and Consumer Health. At Lang & Schwarz the stock trades pre-market at EUR 44.66 on October 26, 2026, 1.55 percent above the Xetra close of October 23, 2026.

Business and reporting context

  • Bayer's core areas are Crop Science, Pharmaceuticals and Consumer Health.
  • Bayer's investor-relations page features Q3 2026 Results.
  • Bayer stock trades pre-market at EUR 44.66 at 8:19 a.m. CET at Lang & Schwarz on October 26, 2026, 1.55 percent above the Xetra close of October 23, 2026.
Bayer AG (DE000BAY0017): Börsen-Editorial-Szene mit DAX-Handelssaal, großen Bildschirmen und abstrakten Pharma-Aktienkursen im Frankfurter Finanzviertel, Illustration mit AI erstellt.

Bayer's investor-relations page lists Crop Science, Pharmaceuticals and Consumer Health as its core business areas, according to Bayer Investor Relations. Bayer stock trades pre-market at EUR 44.66 at 8:19 a.m. CET at Lang & Schwarz on October 26, 2026, 1.55 percent above the Xetra close of October 23, 2026 (EUR 43.98).

Ahead of the Xetra open

The price is EUR 0.68 above the Xetra close. The further course from the Xetra open at 9:00 a.m. CET/CEST is shown by the continuously updated real-time quote of Bayer stock.

Bayer's businesses and reporting

Bayer operates through Crop Science, Pharmaceuticals and Consumer Health. Its investor-relations page features a section titled Q3 2026 Results and says the company publishes quarterly statements for the first and third quarters as well as half-year reports with key financial figures, according to Bayer Investor Relations.

Market context: Market report DAX.

More news and analysis on Bayer stock

Disclaimer...
en | DE000BAY0017 | BAYER | boerse | 70412710 | bgmi